Congenital Heart Diseases
10
1
1
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
10.0%
1 terminated out of 10 trials
66.7%
-19.9% vs benchmark
20%
2 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (10)
Transition From Adolescents to Adulthood for Patients With Congenital Heart Diseases
An International Multicenter, Multivendor Evaluation of the Free-Running Framework for Cardiac Function
Physical Activity and Cognitive Development in Children
Hospital-Based and Home-Based Resistance Training in Adult Congenital Heart Disease
The Role of Multislice Computed Tomography in Congenital Heart Diseases in Paediatric Age Group.
Non-Invasive Shunt Quantification in Interatrial Communication
Pre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery Patients
Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery
"Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects"
The Protective Effects of Sevoflurane in Pediatric Cardiac Surgery